Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,704
datasets available to search
ShareScore release 0.9.0
Dataset results
6,704 results for “reports”
Figure 4 in First report and morphological, molecular characterization of Xiphinema chambersi Thorne, 1939 (Nematoda, Longidoridae) in Canada
Figure 4. Comparison of pharyngeal regions of different stage of juveniles and female of Xiphinema chambersi from Ontario, Canada, A first stage juvenile B second stage juvenile C third stage juvenile D female.
Figure 6 in First report and morphological, molecular characterization of Xiphinema chambersi Thorne, 1939 (Nematoda, Longidoridae) in Canada
Figure 6. Scatter diagram plotting body, odontostyle, and its replacement of individual juveniles and females of X. chambersi from Ontario, Canada.
Figure 2 in First report and morphological, molecular characterization of Xiphinema chambersi Thorne, 1939 (Nematoda, Longidoridae) in Canada
Figure 2. Juveniles and female of Xiphinema chambersi from Ontario, Canada, A first stage juvenile B second stage juvenile C third stage juvenile D female.
Figure 1 in First report and morphological, molecular characterization of Xiphinema chambersi Thorne, 1939 (Nematoda, Longidoridae) in Canada
Figure 1. Drawings of female of Xiphinema chambersi from Ontario, Canada, A entire body B tail region C gonad D pharynx.
IODP Expedition 366 Gas safety report
<p>This composite report returns data from two different gas chromatograph configurations (GC3 and NGA). Each row combines data from several measurements made on the same sample at the same time for a particular headspace or vacutainer sample. If data do not exist for a particular expedition, the column does not appear. Gas samples were measured by gas chromatography and either flame ionization detection (GC-FID) or thermal conductivity detection (GC-TCD). Reported analytes may include methane, ethane, ethene, propane, propene, n-butane, i-butane, n-pentane, i-pentane, n-hexane, i-hexane, n-heptane, i-heptane, nitrogen, oxygen, carbon monoxide, carbon dioxide, and hydrogen sulfide. When data are available, methane to (ethane + ethene) ratio is reported. To identify individual samples and tests, see each separate analysis (GC3, NGAFID, and/or NGATCD).</p>
Appendix. Generic nomenclature adopted in the present paper for the nominal species of the Tortonian, which were previously reported under open generic nomenclature. in Tortonian teleost otoliths from northern Italy: taxonomic synthesis and stratigraphic significance
Appendix. Generic nomenclature adopted in the present paper for the nominal species of the Tortonian, which were previously reported under open generic nomenclature.
Synthetic COVID-19 Case Reporting Data Generated from an Agent-Based Simulation Model
<p>This is a synthetic case reporting data set for the SARS-CoV-2 epidemic in Austria. The data set statistically reproduces and synthetically augments data on reported cases and was generated with an agent-based simulation model. References to descriptions of the model and the parameterization used to generate the data set is included in the attached PDF file. The data format is described in the README file.</p>
MAGIC Deliverable 5.5 - Datasets - Report on the Quality Check of the Robustness of the Narrative behind the Common Agricultural Policy (CAP)
<p>This repository contains datasets used in the production of figures contained in MAGIC Deliverable 5.5</p> <p>Matthews K.B., Blackstock K.L., Waylen K.A., Juarez-Bourke A., Miller D.G., Wardell-Johnson D.H., Rivington M. (2018) Report on the Quality Check of the Robustness of the Narrative behind the Common Agricultural Policy (CAP).</p> <p>MAGIC (H2020-GA 689669) Project Deliverable 5.5 - 29th November 2018</p> <p><a href="https://magic-nexus.eu/documents/d55-report-narratives-behind-cap">MAGIC Deliverable 5.5</a></p>
PharmaCoNER corpus: gold standard annotations of Pharmacological Substances, Compounds and proteins in Spanish clinical case reports
<p><strong>Intro:</strong></p><p>The PharmaCoNER corpus (divided into train, dev and test) is a Gold Standard manually annotated dataset used for the the PharmaCoNER shared task posed at BIONLP-ST (at EMNLP). In addition, we include here the PharmaCoNER background set. It contains the train, development and test sets of the two subtasks (subtask-1 and subtask-2) with Gold Standard annotations. In addition, it contains the documents of the background set, without annotations.</p><p>The PharmaCoNER corpus consists of:</p><ul><li>Manually classified clinical case sections derived from Open access Spanish medical publications, named the Spanish Clinical Case Corpus (SPACCC).</li><li>It was manually selected by a practicing oncologist and revised by a clinical documentalist to assure that records were relevant/representative and resembled structure and content relevant to process clinical records.</li><li>The final corpus: 1000 clinical cases 16,504 sentences</li><li>The corpus contains a total of 396,988 words, with an average of 396.2 words per clinical case.</li><li>It covers a range of medical disciplines including oncology, urology, cardiology, pneumology or infections diseases, etc.</li><li>The corpus has been annotated at the mention level by experts in medicinal chemistry and pharmacology following a granular annotation scheme covering four mention types:<ul><li><i>Entity type 1 (NORMALIZABLES)</i>: mentions of chemicals that can be manually normalized to a unique concept identifier (primarily SNOMED-CT).</li><li><i>Entity type 2 (NO_NORMALIZABLES)</i>: mentions of chemicals that could not be normalized manually to a unique concept identifier.</li><li><i>Entity type 3 (PROTEINAS)</i>: mentions of proteins/genes following an adaptation of the BioCreative GPRO track annotation guidelines (includes peptides, peptide hormones & antibodies).</li><li><i>Entity type 4 (UNCLEAR )</i>: cases of general substance class mentions of clinical relevance, including certain pharmaceutical formulations, general treatments, chemotherapy programs, and vaccines.</li><li>Mentions class "<i>UNCLEAR</i>" (not evaluated for the PharmaCoNER track)</li></ul></li></ul><p> </p><p> </p><p><strong>Please, cite: </strong></p><p>A. G. Agirre, M. Marimon, A. Intxaurrondo, O. Rabal, M. Villegas, M. Krallinger, Pharmaconer: Pharmacological substances, compounds and proteins named entity recognition track, in: Proceedings of The 5th Workshop on BioNLP Open Shared Tasks, 2019, pp. 1–10.</p><p> </p><p><strong>Annotation quality</strong></p><p>Inter-annotator agreement: 93% for annotation, 73% for mapping.</p><p>For more information, see the <a href="https://paperswithcode.com/paper/pharmaconer-pharmacological-substances">paper</a>.</p><p> </p><p><strong>Format</strong></p><p>For subtask 1 annotations are distributed in <i>Brat</i> format. (More info at Brat webpage https://brat.nlplab.org/standoff.html)</p><p>For subtask-2, codes are associated with each document are given in a <i>TSV</i> file with the following columns: </p><blockquote><p>filename code</p></blockquote><p> </p><p><strong>Shared task goal:</strong></p><p>In the two subtasks, the goal is to predict the annotations of the test files (either the ANN files or the TSV with the codes) given only the plain text files. </p><p> </p><p><strong>Resources:</strong></p><ul><li><a href="https://temu.bsc.es/pharmaconer/"><strong>Web</strong></a></li><li><a href="https://www.aclweb.org/anthology/D19-5701.pdf"><strong>Citation</strong></a><strong>: </strong>A. G. Agirre, M. Marimon, A. Intxaurrondo, O. Rabal, M. Villegas, M. Krallinger, Pharmaconer: Pharmacological substances, compounds and proteins named entity recognition track, in: Proceedings of The 5th Workshop on BioNLP Open Shared Tasks, 2019, pp. 1–10.</li><li><a href="https://doi.org/10.5281/zenodo.4271908"><strong>Silver Standard corpus</strong></a></li><li><a href="https://doi.org/10.5281/zenodo.3763276"><strong>Annotation guidelines</strong></a></li><li><a href="https://github.com/TeMU-BSC/PharmaCoNER-Tagger"><strong>PharmaCoNER tagger</strong></a></li><li><a href="https://www.youtube.com/watch?v=B3ZzJl5OMkY"><strong>Youtube video(general setting)</strong></a></li><li><a href="https://www.slideshare.net/MartinKrallinger/pharmaconer-pharmacological-substances-compounds-and-proteins-named-entity-recognition-track-at-bionlpost-workshop-november-4-skycity-rm-2-hong-kong-emnlp2019"><strong>Slides PharmacoNER overview talk at BIONLP-ST / EMNLP </strong></a></li></ul><p>For further information, please visit <a href="https://temu.bsc.es/pharmaconer/">https://temu.bsc.es/pharmaconer/</a> or email us at encargo-pln-life@bsc.es</p><p>Copyright (c) 2018 Secretaría de Estado para el Avance Digital (SEAD)</p><p> </p><p><strong>License</strong></p><p>This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</a>.</p><p> </p><p><strong>Contact</strong></p><p>If you have any questions or suggestions, please contact us at:</p><p><br>- Martin Krallinger (<krallinger [dot] martin [at] gmail [dot] com>)</p><p><strong>Additional resources and corpora</strong></p><p>If you are interested in PharmaCoNER, you might want to check out these corpora and resources:</p><ul><li><a href="https://zenodo.org/records/7614764">DisTEMIST</a> (Corpus of disease mentions and normalization to SNOMED CT, same document collection)</li><li><a href="https://zenodo.org/records/8224056">MedProcNER </a>(Corpus of clinical procedure mentions and normalization to SNOMED CT, same document collection)</li><li><a href="https://zenodo.org/records/8413866">SympTEMIST</a> (Corpus of symptoms, signs and findings mentions and normalization, same document collection)</li><li><a href="https://zenodo.org/records/7116201">MEDDOPROF</a> (Corpus of mentions of professions, occupations and working status and normalization, different document collection with some overlapping documents)</li><li><a href="https://zenodo.org/records/8403498">MEDDOPLACE</a> (Corpus of mentions of place-related entity mentions, including departments, nationalities or patient movements etc.. and normalization, different document collection with some overlapping documents)</li><li><a href="https://zenodo.org/records/4279323">MEDDOCAN</a> (Corpus of mentions of Personal Health Identifiers (PHI), modified synthetic verions of the document collection)</li><li><a href="https://zenodo.org/records/3978041">CANTEMIST</a> (Corpus of cancer tumor morphology mentions and normalization, different document collection)</li><li><a href="https://zenodo.org/records/3837305">CodiESp</a> (Corpus of clinical case reportes with assigned clinical codes from ICD10, Spanish version, same document collection)</li><li><a href="https://zenodo.org/records/7684093">LivingNER</a> (Corpus of mentions of species, including human/family members, pathogens, food, etc.. and normalization to NCBI Taxonomy, different document collection with some overlapping documents)</li><li><a href="https://zenodo.org/records/2560344">SPACCC-POS</a> (Corpus of clinical case reports in Spanish annotated with POS-tags, same document collection)</li><li><a href="https://zenodo.org/records/2560338">SPACCC-TOKEN</a> (Corpus of clinical case reports in Spanish annotated with token-tags (word mention boundaries), same document collection)</li><li><a href="https://zenodo.org/records/2560338">SPACCC-SPLIT</a> (Corpus of clinical case reports in Spanish annotated with sentence boundary-tags, same document collection)</li><li><a href="https://zenodo.org/records/5602914">MESINESP-2</a> (Corpus of manually indexed records with DeCS /MeSH terms comprising scientific literature abstracts, clinical trials, and patent abstracts, different document collection)</li></ul>
MEDDOCAN corpus: gold standard annotations for Medical Document Anonymization on Spanish clinical case reports
<p><strong>Intro:</strong></p> <p>Meddocan shared task dataset (divided in train, dev and test). In addition, we include here the Meddocan background set.</p> <p>It contains the training, development and test sets of the Meddocan shared task with Gold Standard annotations.</p> <p>In addition, it contains the documents of the background set, without annotations.</p> <p> </p> <p><strong>Annotation quality</strong></p> <p>Inter-annotator agreement: 98% </p> <p>For more information, see the <a href="http://ceur-ws.org/Vol-2421/MEDDOCAN_overview.pdf">paper</a>. </p> <p> </p> <p><strong>Format:</strong></p> <p>Annotations are distributed in Brat format. See <a href="https://brat.nlplab.org/standoff.html">Brat webpage</a> for more information.</p> <p>In addition, annotations are also distributed in XML format (based on i2b2 XML format).</p> <p>In the <a href="https://temu.bsc.es/meddocan/index.php/resources/">Meddocan webpage</a>, there is a script to convert between MEDDOCAN-Brat, MEDDOCAN-XML, and i2b2 formats.</p> <p> </p> <p><strong>Shared task goal:</strong></p> <p>In the three subtasks, the goal will be to predict the annotations given only the plain text files. </p> <p> </p> <p><strong>Resources:</strong></p> <ul> <li><strong><a href="https://temu.bsc.es/meddocan/">Web</a></strong></li> <li><strong>Citation: </strong>Montserrat Marimon et al. “Automatic De-identification of Medical Texts in Spanish: the MEDDOCAN Track, Corpus, Guidelines, Methods and Evaluation of Results.” In: IberLEF@ SEPLN. 2019, pp. 618–638.</li> <li><strong>Silver Standard corpus</strong></li> <li><a href="https://doi.org/10.5281/zenodo.4279337"><strong>Annotation guidelines</strong></a></li> </ul> <p> </p> <p>For further information, please visit <a href="https://temu.bsc.es/meddocan/">https://temu.bsc.es/meddocan/</a> or email us at encargo-pln-life@bsc.es</p> <p>Copyright (c) 2019 Secretaría de Estado para el Avance Digital (SEAD)</p>
Shapefiles reporting the boundaries of glaciers analyzed by applying a multifractal approach
<p>We recently investigated the multifractal properties of the perimeters of the Lombardy glaciers in the Italian Alps. We characterized the area and perimeter distributions of the population of glaciers and we showed that the distribution of perimeters exhibits a marked peak, not present in the distribution of areas. We investigated the multifractal spectra of perimeters and we showed that their features are strongly correlated with the area of the glaciers.</p> <p>Here are reported the shapefiles of the boundaries of glaciers of the Lombardia region measured in 2003, 2007, and 2012 that were used for this work.</p>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Sweden
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Slovakia
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Norway
<p>This dataset contains the results of the surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Slovenia
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - The United Kingdom
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund</li> </ul> <p>Disclaimer: Data collected by the UK at national level prior to 31/01/2020 has been used in EFSA data reports as is related to a period in which this country was still a European Union Member State.</p>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Malta
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Portugal
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union - Ireland
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
AI results complementing the Annual Report on surveillance for Avian Influenza in poultry and wild birds in Member States of the European Union- The Netherlands
<p>This dataset contains the results of the EU co-funded surveillance activities conducted in 2019, which consisted of:</p> <ul> <li>Serological surveys to monitor the circulation of AIV subtypes H5 and H7 in poultry (active surveillance). These surveys should preferentially target poultry species or production systems with increased risk for introduction of avian influenza (AI).</li> <li>Passive surveillance aiming at the virological detection of AI in wild birds found dead or moribund.</li> </ul>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.